Australian Athletics confirms that it has imposed a 12-month period of Ineligibility on athlete Olufemi Komolafe for Anti-Doping Rule Violations (ADRVs) of Presence and Use of a Prohibited Substance, following a matter managed in partnership with Sport Integrity Australia (SIA).
Komolafe returned an Adverse Analytical Finding from an In-Competition doping control test on 6 April 2026 at the Stawell Gift for the presence of D-Amfetamine/Dextroamfetamine.
The 12-month period of ineligibility is backdated to the start of his Provisional Suspension on 2 July 2026. Komolafe is ineligible to participate in all sports that have adopted the WADA Code until 11:59pm on 1 July 2027. He is also not permitted to compete in a non-signatory professional league, or in an event organised by a non-signatory international or national level event organisation.
Under the Australian National Anti-doping Policy 2021 (ANADP), any medals, points or prizes obtained by Mr Komolafe from 6 April 2026 onwards are forfeited which includes the prize money he won in the 2026 Stawell Gift Final.
Australian Athletics strongly condemns the use of performance-enhancing substances and remains committed to clean sport. We work in partnership with SIA to promote a fair and safe environment for all athletes, including delivering education and prevention programs at all levels of the sport. Australian Athletics reminds athletes, coaches and their support networks that stimulant medications, including methylphenidate (for example Ritalin, Concerta) and dexamphetamine/D-Amfetamine/Dextroamfetamine (for example Vyvanse), are prohibited In-Competition and require a Therapeutic Use Exemption (TUE). To be considered for a TUE, athletes must have a formal diagnosis, relevant documentation and a valid prescription.
The matter is published on the SIA Violations List in accordance with the Sport Integrity Australia Act 2020 (Cth) and ANADP HERE
Australian Athletics
Posted 19/`11/2026